People

Celebrities and Royals from around the world. Right on schedule.

News

Daily news and events, covered by our international photographers.

Features

Odd, funny and touchy images. Be amazed.

Styling

Fashion and design trends.

Portrait

Premium Portraiture.

Reportage

In-depth Coverage.

Creative

Selected stock imagery.

Dukas Bildagentur
request@dukas.ch
+41 44 298 50 00

Your search:

171 result(s) in 2 ms

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131432_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig - a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131433_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131475_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131415_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131413_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131467_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131472_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131435_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131485_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131488_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131431_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131418_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131478_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131469_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    DUKAS_128131483_EYE
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen
    ‘They said we were eccentrics’: the UK team developing clean aviation fuel. In the search for sustainable flying, Cranfield University might have found the answer in hydrogen. Two projects pioneered at Cranfield are using hydrogen in the form of fuel cells to power electric motors and propel planes: ZeroAvia flew a six-seater from here last September, and hopes to scale up the technology for commercial short-haul flights in the coming decades. Another, Project Fresson, is planning to use fuel cells for a green, short-hop passenger service around the Orkney islands as soon as 2023.
    Hydrogen fuel test rig demonstration with Bobby Sethi. Bobby talks through a low nox hydrogen micromix combustion test rig, which is designed to replicate the conditions of combustion at cruising altitude. Aviation technological research, involving electric planes, hydrogen labratories and other green innovations. Cranfield University. Milton Keynes.
    © David Levene / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629658_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629666_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629659_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629679_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured playing on his drum set.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629681_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured playing on his drum set.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629667_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629668_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629664_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629662_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629665_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629672_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with mum Kristina Gray and pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629661_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629660_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629663_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629675_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629670_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629669_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629671_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629677_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629678_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629680_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629676_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629674_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629673_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    DUKAS_118629682_EYE
    ‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
    ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
    Sanuel is pictured with pet dog Hamish.
    Photo by Fabio De Paola** Clearance required prior to publication**
    © Fabio De Paola / Guardian / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    © Guardian / eyevine. All Rights Reserved.

     

  • Heston Blumenthal
    DUKAS_104973016_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Heston Blumenthal
    DUKAS_104973019_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Heston Blumenthal
    DUKAS_104973018_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Heston Blumenthal
    DUKAS_104973020_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Heston Blumenthal
    DUKAS_104973015_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Heston Blumenthal
    DUKAS_104973014_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Heston Blumenthal
    DUKAS_104973021_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Heston Blumenthal
    DUKAS_104973017_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Heston Blumenthal
    DUKAS_104973022_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Heston Blumenthal
    DUKAS_104973023_EYE
    Heston Blumenthal
    Heston Blumenthal at his restaurant 'Dinner' at the Mandarin Oriental, Knightsbridge, London, UK.
    © Rii Schroer / eyevine

    Contact eyevine for more information about using this image:
    T: +44 (0) 20 8709 8709
    E: info@eyevine.com
    http://www.eyevine.com
    (FOTO: DUKAS/EYEVINE)
    Rii Schroer / eyevine

     

  • Next page